BNR Shares Bulletin Resources Limited
ASX · ASXLast in our picks 2026-09-29 — not in the current list; analysis below is from that screen
Highly speculative neuroscience biotech with meaningful binary upside from trial success.
Signal breakdown
- ▸Event-driven catalyst, but execution risk remains high.
- ▾Below 50-day MA (-10.46%)
Is BNR a buy right now?
Trend: BNR is trading below the 50-day average (-10.00%), RSI 43 — neutral momentum, with a 3-month return of -27.03%.
Valuation & quality: Bulletin Resources Limited trades on price-to-book 0.60; fundamentals show net margin 0.0%, return on equity -4.2%.
Our screen: WATCH (score 0) — Highly speculative neuroscience biotech with meaningful binary upside from trial success.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -16.70% | -20.00% | +0.00% | +0.00% | +0.00% | -25.00% | +0.00% | +0.00% |
Fundamentals
Technical signals
About Bulletin Resources Limited
Bulletin Resources Limited, together with its subsidiaries, operates as a mineral exploration company in Australia. It explores for gold, lithium, and other mineral deposits. The company was formerly known as Bulletin Resources Pty Ltd and changed its name to Bulletin Resources Limited in December 2010.
Sector: Basic Materials · Industry: Gold · Australia · 3 employees · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.